scientific article published on 11 November 2014 · A phase I monotherapy study of RG7212, a first-in-class monoclonal antibody targeting TWEAK signaling in patients with advanced cancers · YYNN

A phase I monotherapy study of RG7212, a first-in-class monoclonal antibody targeting TWEAK signaling in patients with advanced cancers

? TBD

scientific article published on 11 November 2014

Ratings
0

Nobody has rated this yet. Be the first!

Lists
0

Instance of

Scholarly article

Author

Morten Mau-Sorensen

Jan H M Schellens

Subject

Monoclonal antibody

Wikidata